This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Tezspire (tezepelumab-ekko) is a monthly injection used to treat severe asthma. It was approved by the FDA in 2021 for use in addition to other asthma controlling medicines in people 12 and older.

Asthma care continues to develop, particularly in how treatment and long-term management are approached. This article outlines current treatment and management recommendations for patients aged 12 and ...

Black and Latinx patients bear a disproportionate burden of asthma. Efforts to reduce the disproportionate morbidity have been mostly unsuccessful, and guideline recommendations have not been based on ...

Scientists working in the School of Biochemistry and Immunology at the Trinity Biomedical Sciences Institute (TBSI) report they have uncovered a new strategy in mice for treating severe asthma. The ...

Though they’re separate conditions, allergic rhinitis and asthma are both atopic diseases. Allergies can trigger asthma, and having asthma can increase your risk for allergic rhinitis. Allergic ...

Exposure to more germs may backfire for adult asthma sufferers In A Nutshell A new mouse study from Cornell University found that adult mice exposed to a wide variety of microbes developed more severe ...